日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment

质子泵抑制剂联合帕博西尼或阿贝西利治疗内分泌敏感性乳腺癌

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-026-39093-3
Takada, Shinya; Takahashi, Kaori; Uozumi, Ryuji; Mukohara, Toru; Hayashida, Tetsu; Iwabe, Midori; Iihara, Hirotoshi; Kusuhara-Mamishin, Kanako; Tahatsu, Kanae; Kitagawa, Yuko; Tsuchiya, Masami; Kitahora, Mika; Umehara, Kengo; Nagayama, Aiko; Kosaka, Shinkichi; Asano-Niwa, Yoshimi; Watanabe, Kenichi; Seki, Tomoko; Ohnuki, Koji; Futamura, Manabu; Kawazoe, Hitoshi; Nakamura, Tomonori
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer

质子泵抑制剂和细胞周期蛋白依赖性激酶4/6抑制剂在乳腺癌患者中的应用

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae015
Takahashi, Kaori; Uozumi, Ryuji; Mukohara, Toru; Hayashida, Tetsu; Iwabe, Midori; Iihara, Hirotoshi; Kusuhara-Mamishin, Kanako; Kitagawa, Yuko; Tsuchiya, Masami; Kitahora, Mika; Nagayama, Aiko; Kosaka, Shinkichi; Asano-Niwa, Yoshimi; Seki, Tomoko; Ohnuki, Koji; Suzuki, Akio; Ono, Fumiko; Futamura, Manabu; Kawazoe, Hitoshi; Nakamura, Tomonori
肿瘤
肿瘤免疫
信号转导
乳腺癌
细胞生物学
发表日期：2024
文献求助 收藏

Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study

曲妥珠单抗德鲁替康诱发恶心呕吐的双联或三联止吐预防：一项开放标签、随机、多中心探索性 II 期研究

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.87169
Iihara, Hirotoshi; Shimokawa, Mototsugu; Bando, Hiroko; Niwa, Yoshimi; Mizuno, Yutaka; Kawaguchi, Yoshihiro; Kitahora, Mika; Murakami, Akari; Kawai, Masaaki; Ishida, Kazushige; Takeuchi, Makoto; Ishihara, Kazuhiro; Iyoda, Tomokazu; Nakada, Takumi; Ogiso, Atsuko; Kojima, Yasuyuki; Kumagai, Fumiyoshi; Sawa, Aya; Mori, Ryutaro; Higuchi, Kosuke; Furuta, Tomoko; Kamei, Yoshiaki; Tsuchiya, Masami; Terasaki, Azusa; Yamamoto, Senri; Kitazawa, Mai; Okazaki, Mai; Suzuki, Akio; Futamura, Manabu
发表日期：2023
文献求助 收藏

Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy

药物干预可改善接受门诊化疗的癌症患者的生活质量，有效应对不良事件

期刊:Journal of Pharmaceutical Health Care and Sciences
影响因子:1.2
doi:10.1186/s40780-022-00239-w
Fujii, Hironori; Ueda, Yukino; Hirose, Chiemi; Ohata, Koichi; Sekiya, Kumiko; Kitahora, Mika; Sadaka, Shiori; Yamamoto, Senri; Watanabe, Daichi; Kato-Hayashi, Hiroko; Iihara, Hirotoshi; Kobayashi, Ryo; Kaburaki, Miho; Matsuhashi, Nobuhisa; Takahashi, Takao; Makiyama, Akitaka; Yoshida, Kazuhiro; Hayashi, Hideki; Suzuki, Akio
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study

贝伐珠单抗联合TAS-102治疗可改善难治性转移性结直肠癌患者的临床结局：一项回顾性研究

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0541
Fujii, Hironori; Matsuhashi, Nobuhisa; Kitahora, Mika; Takahashi, Takao; Hirose, Chiemi; Iihara, Hirotoshi; Yamada, Yunami; Watanabe, Daichi; Ishihara, Takuma; Suzuki, Akio; Yoshida, Kazuhiro
肿瘤
肠癌
肿瘤免疫
发表日期：2020
文献求助 收藏

Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy

真实世界数据揭示了门诊癌症化疗患者生活质量（采用 EuroQol 5 维度 5 级效用值评估）与不良事件之间的关联

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-020-05443-8
Hirose, Chiemi; Fujii, Hironori; Iihara, Hirotoshi; Ishihara, Masashi; Nawa-Nishigaki, Minako; Kato-Hayashi, Hiroko; Ohata, Koichi; Sekiya, Kumiko; Kitahora, Mika; Matsuhashi, Nobuhisa; Takahashi, Takao; Okuda, Kumiko; Naruse, Masayo; Ishihara, Takuma; Sugiyama, Tadashi; Yoshida, Kazuhiro; Suzuki, Akio
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏